Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A single-centre study of the clinical efficacy of Eakin cohesive paste
ISRCTN ISRCTN99356681
ClinicalTrials.gov identifier
Public title A single-centre study of the clinical efficacy of Eakin cohesive paste
Scientific title
Acronym N/A
Serial number at source TGE/P01
Study hypothesis Eakin cohesive paste is safe for use on patients with high output wounds and stomas.
Lay summary
Ethics approval Favourable ethical opinion received 16th September 2005.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stoma, ostomy, wound and fistula
Participants - inclusion criteria Patients presenting wounds, stomas and fistulae with greater than 200 ml exudate per day.
Participants - exclusion criteria Patients will be excluded from the study under the following circumstances:
1. Where informed consent is withheld
2. Where the patient is unable to give informed consent due to legal incompetence
3. Where, in the physician's opinion, inclusion in the trial is not advised
4. Where the patient is presenting a critical wound, or is in an emergency situation
5. Where the patient is in the intensive care unit
6. Where there is an open wound in the peristomal region (for stoma patients only)
7. Where the patient is currently participating in another clinical trial
8. Where the patient has a known sensitivity to the product or any of its ingredients
8. Where the patient currently uses stoma paste as part of their regular pouching regime
Anticipated start date 01/06/2005
Anticipated end date 01/10/2005
Status of trial Completed
Patient information material
Target number of participants 40
Interventions The trial is a randomised cross over trial. Patients will be assigned a patient identity number and will then be randomly
assigned either to begin with their normal pouching regime or their normal pouching regime and Eakin cohesive paste. At the half way point the treatment will be
switched.
Primary outcome measure(s) Confirmation of the safety and efficacy of Eakin cohesive paste
Secondary outcome measure(s) Determination of whether Eakin cohesive paste increases the pouch weartime on high output wounds.
Sources of funding T G Eakin Limited
Trial website http://www.eakin.co.uk
Publications
Contact name Ms  Marie  McGrogan
  Address Royal Group of Hospitals Trust
Grosvenor Road
  City/town Belfast
  Zip/Postcode BT12 6BX
  Country United Kingdom
Sponsor T G Eakin Limited (UK)
  Address 15 Ballystockart Road
  City/town Comber
  Zip/Postcode BT23 5QY
  Country United Kingdom
  Sponsor website: http://www.eakin.co.uk
Date applied 24/01/2005
Last edited 14/12/2010
Date ISRCTN assigned 16/03/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central